Gsa Capital Partners LLP Athenex, Inc. Transaction History

Gsa Capital Partners LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.24 - $1.11 $236,454 - $1.09 Million	985,227 Added 206.75%	1,461,761 $394,000
Q2 2022 Aug 09, 2022	BUY	$0.41 - $0.91 $100,324 - $222,670	244,693 Added 105.54%	476,534 $195,000
Q1 2022 May 11, 2022	SELL	$0.79 - $1.59 $236,673 - $476,343	-299,587 Reduced 56.37%	231,841 $192,000
Q4 2021 Feb 14, 2022	BUY	$1.36 - $2.94 $669,133 - $1.45 Million	492,010 Added 1248.19%	531,428 $723,000
Q3 2021 Nov 12, 2021	BUY	$2.97 - $4.84 $117,071 - $190,783	39,418 New	39,418 $119,000
Q2 2021 Aug 05, 2021	SELL	$3.71 - $5.13 $345,386 - $477,582	-93,096 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$4.08 - $14.75 $217,814 - $787,443	53,386 Added 134.44%	93,096 $400,000
Q4 2020 Feb 03, 2021	BUY	$11.06 - $14.01 $439,192 - $556,337	39,710 New	39,710 $439,000
Q3 2020 Nov 06, 2020	SELL	$10.26 - $14.55 $155,726 - $220,839	-15,178 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$7.11 - $13.76 $107,915 - $208,849	15,178 New	15,178 $209,000
Q4 2019 Feb 12, 2020	SELL	$9.6 - $17.75 $137,913 - $254,996	-14,366 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$12.16 - $21.0 $174,690 - $301,686	14,366 New	14,366 $175,000
Q2 2019 Aug 06, 2019	SELL	$9.44 - $19.8 $220,896 - $463,320	-23,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.11 - $13.49 $259,974 - $315,666	23,400 New	23,400 $287,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.